Alterations in Cytokine Profile and Dendritic Cells Subsets in Peripheral Blood of Rheumatoid Arthritis Patients before and after Biologic Therapy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  2009-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1749-6632.2009.04740.xPMID 19758170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RADIATE: more treatment options for patients with an inadequate response to tumor necrosis factor antagonists

  2009cited by this paper
• Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes.

  2009cited by this paper
• Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms.

  2009cited by this paper
• Induction and effector functions of TH17 cells

  2008cited by this paper
• Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy

  2008cited by this paper
• Abatacept: the first T lymphocyte co-stimulation modulator, for the treatment of rheumatoid arthritis

  2008cited by this paper
• Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept.

  2008cited by this paper
• The importance of the baseline Disease Activity Score 28 in determining responders and non-responders to anti-TNF in UK clinical practice.

  2008cited by this paper
• IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?

  2008cited by this paper
• The role and therapeutic implications of fibroblast‐like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis

  2008cited by this paper
• Distribution of myeloid dendritic cells and plasmacytoid dendritic cells in the synovial tissues of rheumatoid arthritis.

  2008cited by this paper
• IL-17 family cytokines and the expanding diversity of effector T cell lineages.

  2007cited by this paper
• The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence.

  2007cited by this paper
• The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence

  2007cited by this paper
• Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis.

  2007cited by this paper
• Reduced blood BDCA‐2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus

  2005cited by this paper
• Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis

  2005cited by this paper
• Tolerogenic dendritic cells.

  2003cited by this paper
• Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation.

  2003cited by this paper
• Blood dendritic cells and DC-poietins in systemic lupus erythematosus.

  2002cited by this paper
• In vivo activated T cells in rheumatoid synovitis. Analysis of Th1‐ and Th2‐type cytokine production at clonal level in different stages of disease

  2002cited by this paper
• Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.

  2001cited by this paper
• Cytokine blockade as a new strategy to treat rheumatoid arthritis: inhibition of tumor necrosis factor.

  2000cited by this paper
• BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood

  2000cited by this paper
• Depletion in blood CD11c-positive dendritic cells from HIV-infected patients.

  1999cited by this paper
• Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

  1999cited by this paper
• Biologic therapies in rheumatoid arthritis

  1999cited by this paper
• The nature of the principal type 1 interferon-producing cells in human blood.

  1999cited by this paper
• The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis.

  1998cited by this paper
• Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis

  1995cited by this paper
• Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

  1995cited by this paper
• Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis.

  1995cited by this paper
• Synovial tissue macrophages and joint erosion in rheumatoid arthritis.

  1994cited by this paper
• Interleukin-6 Antibodies in Rheumatoid Arthritis

  1994cited by this paper
• Development of a disease activity score based on judgment in clinical practice by rheumatologists.

  1993cited by this paper
• Validity of single variables and indices to measure disease activity in rheumatoid arthritis.

  1993cited by this paper
• Validity of single variables and indices to measure disease activity in rheumatoid arthritis.

  1993cited by this paper
• Development of a disease activity score based on judgment in clinical practice by rheumatologists.

  1993cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper

• Classical proinflammatory cytokines in patients with rheumatoid arthritis: immunologic and clinical relationships

  2024cites this paper
• Role of IL‐6 in dendritic cell functions

  2021cites this paper
• Response to abatacept is associated with the inhibition of proteasome β1i expression in T cells of patients with rheumatoid arthritis

  2020cites this paper
• Transcriptional signature associated with early rheumatoid arthritis and healthy individuals at high risk to develop the disease

  2018cites this paper
• Significant IFNγ responses of CD8+ T cells in CMV-seropositive individuals with autoimmune arthritis.

  2016cites this paper
• Lupus nephritis: the evolving role of novel therapeutics.

  2014cites this paper
• Ingested (oral) tocilizumab inhibits EAE.

  2014cites this paper
• Reduction of Serum ADAM17 Level Accompanied with Decreased Cytokines after Abatacept Therapy in Patients with Rheumatoid Arthritis

  2014cites this paper
• Reduction of peripheral blood T cells producing IFN-γ and IL-17 after therapy with abatacept for rheumatoid arthritis.

  2014cites this paper
• UvA-DARE ( Digital Academic Repository ) Dendritic cells manipulating immune responses : Understanding the role of Flt 3 L and Flt 3-dependent DCs in rheumatic diseases

  2014influential citation
• Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects.

  2014cites this paper
• Targeting CD4+CD28- T cells by blocking CD28 co-stimulation.

  2013cites this paper
• Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis.

  2013cites this paper
• Immunological profile of 110 rheumatoid arthritis

  2013cites this paper
• Allogeneic Murine Mesenchymal Stem Cells: Migration to Inflamed Joints In Vivo and Amelioration of Collagen Induced Arthritis When Transduced to Express CTLA4Ig

  2013cites this paper
• HLA-G may predict the disease course in patients with early rheumatoid arthritis.

  2013cites this paper
• Current data on IL-17 and Th17 cells and implications for graft versus host disease

  2013cites this paper
• Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement

  2013cites this paper
• Tocilizumab Treatment Decreases Circulating Myeloid Dendritic Cells and Monocytes, 2 Components of the Myeloid Lineage

  2012cites this paper
• Induction of immune tolerance in the treatment of rheumatoid arthritis

  2011cites this paper
• Baseline Numbers of Circulating CD28-negative T Cells May Predict Clinical Response to Abatacept in Patients with Rheumatoid Arthritis

  2011cites this paper
• Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation?

  2011cites this paper
• [CTLA4-Ig interferes and downregulates the proinflammatory activities of rheumatoid synovial macrophages in monoculture].

  2011cites this paper
• Response to Abatacept in Patients with Rheumatoid Arthritis Baseline Numbers of Circulating CD 28-negative T Cells May Predict Clinical

  2011cites this paper
• Rheumatoid arthritis and salivary biomarkers of periodontal disease.

  2010cites this paper
• Innate immunity and rheumatoid arthritis.

  2010cites this paper
• Anti-interleukin 6: first line in rheumatoid arthritis?

  2009cites this paper